Chen Porat
Vorstandsvorsitzender bei Endobetix Ltd.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Shlomo Lewkowicz | M | - |
Endobetix Ltd.
 Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | 12 Jahre |
| D. Dollinger | M | - |
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | - |
| Eran Feldhay | M | - |
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Pierre Sharvit | M | - |
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | - |
| Yuval Yanai | M | 71 |
Endobetix Ltd.
Endobetix Ltd. Medical SpecialtiesHealth Technology Endobetix Ltd. develops a nonsurgical implant that mimics the hormonal benefits offered by bariatric surgery. It offers Endobetix Bile Diversion Device which changes the hormonal balance and induces the release of key hormones such as GLP-1 to improve glucose tolerance and reduce fat absorption. The company was founded by Chen Porat, Pierre Sharvit, and Shlomo Lewkowicz in 2012 and is headquartered in Misgav, Israel. | 2 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Israel | 5 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Chen Porat
- Persönliches Netzwerk